References

10.1128/cmr.11.4.589

10.1128/cmr.11.4.589 · External reference

Identification of Biomarkers for Differentiation of Hypervirulent Klebsiella pneumoniae from Classical K. pneumoniae

2018 · External reference

10.1086/595011

10.1086/595011 · External reference

Whole genome sequence revealed the fine transmission map of carbapenem-resistant Klebsiella pneumonia isolates within a nosocomial outbreak

10.1186/s13756-018-0363-8 · 2018 · External reference

Emerging severe and fatal infections due to Klebsiella pneumoniae in two university hospitals in France

10.1128/jcm.00676-11 · 2011 · External reference

Risk factors and clinical outcomes of hypervirulent Klebsiella pneumoniae induced bloodstream infections

10.1007/s10096-017-3160-z · 2018 · External reference

Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess

10.1086/519262 · 2007 · External reference

10.1128/mmbr.00078-15

10.1128/mmbr.00078-15 · External reference

10.1128/cmr.00001-19

10.1128/cmr.00001-19 · External reference

10.1016/s1473-3099(12)70205-0

10.1016/s1473-3099(12)70205-0 · External reference

Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis

10.1093/jac/dkz446 · 2020 · External reference

First isolate of KPC-2-producing Klebsiella pneumonaie sequence type 23 from the Americas

10.1128/jcm.00726-14 · 2014 · External reference

Identification of a Carbapenemase-Producing Hypervirulent Klebsiella pneumoniae Isolate in the United States

10.1128/aac.00519-19 · 2019 · External reference

10.1016/s1473-3099(17)30489-9

10.1016/s1473-3099(17)30489-9 · External reference

In Vitro Activity of Ceftazidime-Avibactam against Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae Isolates

2018 · External reference

Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae

10.1093/cid/cix783 · 2018 · External reference

Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by MBL- producing Enterobacterales

2020 · External reference

10.1128/iai.72.12.7107-7114.2004

10.1128/iai.72.12.7107-7114.2004 · External reference

Persistence of Antibiotic Resistance and Capsule in E. coli B23 after Removal from Sublethal Kanamycin Treatment. Journal of Experimental

2011 · External reference

Effects of streptomycin and kanamycin on the production of capsular polysaccharides in Escherichia coli B23 cells

2007 · External reference

10.1371/journal.ppat.1004691

10.1371/journal.ppat.1004691 · External reference

Convergence of carbapenem-resistance and hypervirulence in Klebsiella pneumoniae

10.1016/s1473-3099(17)30517-0 · 2018 · External reference

10.1371/journal.pcbi.1005595

10.1371/journal.pcbi.1005595 · External reference

Unresolved reference

2019 · External reference

In vitro Optimization of Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae

10.3389/fmicb.2021.618087 · 2021 · External reference

Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6')-Ib

10.1093/jac/dkaa480 · 2021 · External reference

Rise and dissemination of aminoglycoside resistance: the aac(6')-Ib paradigm

10.3389/fmicb.2013.00121 · 2013 · External reference

Aminoglycoside 6'-N-acetyltransferase variants of the Ib type with altered substrate profile in clinical isolates of Enterobacter cloacae and Citrobacter freundii

10.1128/aac.42.2.209 · 1998 · External reference

A 4.5-Year Within-Patient Evolution of a Colistin-Resistant Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Sequence Type 258

10.1093/cid/ciy293 · 2018 · External reference

Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC(6')-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro

10.1128/aac.01489-13 · 2013 · External reference

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

10.1002/phar.2209 · 2019 · External reference

10.1093/bioinformatics/btu170

10.1093/bioinformatics/btu170 · External reference

10.1038/nmeth.1923

10.1038/nmeth.1923 · External reference

10.1093/bioinformatics/btu638

10.1093/bioinformatics/btu638 · External reference

10.1186/s13059-014-0550-8

10.1186/s13059-014-0550-8 · External reference

10.1093/nar/gky1085

10.1093/nar/gky1085 · External reference

10.1016/j.jmb.2015.11.006

10.1016/j.jmb.2015.11.006 · External reference

10.1089/omi.2011.0118

10.1089/omi.2011.0118 · External reference

10.1093/cid/ciy660

10.1093/cid/ciy660 · External reference

Emergence of OXA-232-producing hypervirulent Klebsiella pneumoniae ST23 causing neonatal sepsis

10.1093/jac/dkaa080 · 2020 · External reference

The emergence of the hypervirulent Klebsiella pneumoniae (hvKp) strains among circulating clonal complex 147 (CC147) harbouring blaNDM/OXA-48 carbapenemases in a tertiary care center of Iran

10.1186/s12941-020-00349-z · 2020 · External reference

A case of NDM-carbapenemase-producing hypervirulent Klebsiella pneumoniae sequence type 23 from the UK

10.1099/jmmcr.0.005130 · 2018 · External reference

Primary osteomyelitis caused by an NDM-1-producing K. pneumoniae strain of the highly virulent sequence type 23. Emerg

2017 · External reference

In vitro Activity of Apramycin Against Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae Isolates

10.3389/fmicb.2020.00425 · 2020 · External reference

Ceftazidime/avibactam versus standard-of-care agents against carbapenem-resistant Enterobacteriaceae harbouring blaKPC in a one-compartment pharmacokinetic/pharmacodynamic model

10.1093/jac/dky213 · 2018 · External reference

Pharmacodynamics of Ceftazidime plus Avibactam against KPC-2-Bearing Isolates of Klebsiella pneumoniae in a Hollow Fiber Infection Model

10.1128/aac.00462-19 · 2019 · External reference

Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae

10.1128/aac.00692-21 · 2021 · External reference

Searching for the Optimal Treatment for Metallo- and Serine-beta-Lactamase Producing Enterobacteriaceae: Aztreonam in Combination with Ceftazidime-avibactam or Meropenem-vaborbactam

2019 · External reference

Can Ceftazidime-Avibactam and Aztreonam Overcome beta-Lactam Resistance Conferred by Metallo-beta-Lactamases in Enterobacteriaceae?

10.1128/aac.02243-16 · 2017 · External reference

Determining the optimal dosing of a novel combination regimen of ceftazidime/avibactam with aztreonam against NDM-1-producing Enterobacteriaceae using a hollow-fibre infection model

2020 · External reference

10.1371/journal.pone.0039451

10.1371/journal.pone.0039451 · External reference

10.1021/pr100740w

10.1021/pr100740w · External reference

10.1074/jbc.m512365200

10.1074/jbc.m512365200 · External reference

10.1080/20477724.2018.1538281

10.1080/20477724.2018.1538281 · External reference

10.3389/fmicb.2014.00070

10.3389/fmicb.2014.00070 · External reference

10.1128/aac.01794-15

10.1128/aac.01794-15 · External reference

Improving 1,3-propanediol production from glycerol in a metabolically engineered Escherichia coli by reducing accumulation of sn-glycerol-3-phosphate

10.1021/bp020281+ · 2002 · External reference

10.1128/jb.00369-06

10.1128/jb.00369-06 · External reference

10.1186/1471-2180-6-53

10.1186/1471-2180-6-53 · External reference

10.1016/j.jprot.2013.12.024

10.1016/j.jprot.2013.12.024 · External reference

10.1002/pmic.200500219

10.1002/pmic.200500219 · External reference

Proteomic Changes of Klebsiella pneumoniae in Response to Colistin Treatment and crrB Mutation-Mediated Colistin Resistance

2020 · External reference

10.1128/mbio.00603-20

10.1128/mbio.00603-20 · External reference

10.1073/pnas.1401876111

10.1073/pnas.1401876111 · External reference

10.1126/science.1232751

10.1126/science.1232751 · External reference

Transcriptional Landscape of a bla (KPC-2) Plasmid and Response to Imipenem Exposure in Escherichia coli TOP10

10.3389/fmicb.2018.02929 · 2018 · External reference

Bacterial persistence induced by salicylate via reactive oxygen species

10.1038/srep43839 · 2017 · External reference

Mechanisms of bacterial persistence during stress and antibiotic exposure

10.1126/science.aaf4268 · 2016 · External reference

Transcriptomic responses of a New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae isolate to the combination of polymyxin B and chloramphenicol

10.1016/j.ijantimicag.2020.106061 · 2020 · External reference